1. Jin, Kun, Qiu, Shi, Chen, Bo, Ai, Jianzhong, Wei, Qiang. 2023. DOK3 promotes proliferation and inhibits apoptosis of prostate cancer via the NF-κB signaling pathway. In Chinese medical journal, 136, 423-432. doi:10.1097/CM9.0000000000002251. https://pubmed.ncbi.nlm.nih.gov/36867541/
2. Liu, Ning, Liu, Xiaofeng, Li, Xiaoou, Yu, Xiuyan, Peng, Qisheng. . DOK3 Degradation is Required for the Development of LPS-induced ARDS in Mice. In Current gene therapy, 16, 256-262. doi:10.2174/1566523216666161103142342. https://pubmed.ncbi.nlm.nih.gov/28590889/
3. Yang, Yong-Yu, Ye, Ling, Chen, Jing, Yin, Ya-Ling, Li, Peng. 2021. Dok3 is involved in cisplatin-induced acute kidney injury via regulation of inflammation and apoptosis. In Biochemical and biophysical research communications, 569, 132-138. doi:10.1016/j.bbrc.2021.06.097. https://pubmed.ncbi.nlm.nih.gov/34245977/
4. Loh, Jia Tong, Lee, Koon-Guan, Lee, Alison P, Tan, Andy Hee-Meng, Lam, Kong-Peng. 2021. DOK3 maintains intestinal homeostasis by suppressing JAK2/STAT3 signaling and S100a8/9 production in neutrophils. In Cell death & disease, 12, 1054. doi:10.1038/s41419-021-04357-5. https://pubmed.ncbi.nlm.nih.gov/34743196/
5. Gao, Wen-Shuang, Qu, Yu-Juan, Huai, Juan, Zhang, Yang, Yue, Shou-Wei. 2020. DOK3 is involved in microglial cell activation in neuropathic pain by interacting with GPR84. In Aging, 13, 389-410. doi:10.18632/aging.202144. https://pubmed.ncbi.nlm.nih.gov/33281117/
6. Ohsugi, Takeo. 2017. Effects of expressing human T-cell leukemia virus type 1 (HTLV-I) oncoprotein Tax on DOK1, DOK2 and DOK3 gene expression in mice. In The Journal of veterinary medical science, 79, 935-938. doi:10.1292/jvms.17-0034. https://pubmed.ncbi.nlm.nih.gov/28302940/
智鼠故事 
